Role of Hypoxia-inducible factor-1α and Survivin in colorectal carcinoma progression

International Journal of Colorectal Disease

Volumn 23, Issue 11, 2008, Pages 1057-1064

  Fan, Li Fang ^a,b   Dong, Wei Guo ^b   Jiang, Cong Qing ^c   Qian, Qun ^c   Yu, Qiong Fang ^b  

^a WUHAN UNIVERSITY   (China)

^b RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^c WUHAN UNIVERSITY   (China)

Author keywords

Colorectal carcinoma; Hypoxia inducible factor 1 ; Small interfering RNA; Survivin

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; SMALL INTERFERING RNA; SURVIVIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER GROWTH; CELL HYPOXIA; COLORECTAL CARCINOMA; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GENE OVEREXPRESSION; GENE TARGETING; GENETIC ASSOCIATION; GENETIC CORRELATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; TISSUE MICROARRAY; WESTERN BLOTTING;

BLOTTING, WESTERN; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; MICROTUBULE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; NEOPLASM STAGING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; RNA, SMALL INTERFERING; TUMOR MARKERS, BIOLOGICAL;

EID: 54049115847     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-008-0511-3     Document Type: Article

References (29)

1. Hochachka PW, Buck LT, Doll CJ, Land SC (1996) Unifying theory of hypoxia tolerance: Molecular/metabolic defense and rescue mechanisms for surviving oxygen lack. Proc Natl Acad Sci USA 93:9493-9498
2. Semenza GL, Wang GL (1992) A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol 12:5447-54543
3. Wang GL, Semenza GL (1995) Purification and characterization of hypoxia-inducible factor 1. J Biol Chem 270:1230-1237
4. Pouyssegur J, Dayan F, Mazure NM (2006) Hypoxia signalling in cancer and approaches to enforce tumor regression. Nature 441:437-443
5. Jiang CQ, Liu ZS, Fan LF, Liu ZS, Qian Q, Xia D, Diao LM, He YM, Ai ZL (2004) Expression levels and significance of hypoxia inducible factor-1 alpha and vascular endothelial growth factor in human colorectal adenocarcinoma. Chin Med J 117:1541-1546
6. Bache M, Holzapfel D, Kappler M, Holzhausen HJ, Taubert H, Dunst J, Hänsgen G (2007) Survivin protein expression and hypoxia in advanced cervical carcinoma of patients treated by radiotherapy. Gynecol Oncol 104:139-144
7. Haberler C, Slavc I, Czech T, Gelpi E, Heinzl H, Budka H, Urban C, Scarpatetti M, Ebetsberger-Dachs G, Schindler C, Jones N, Klein-Franke A, Maier H, Jauk B, Kiefer A, Hainfellner JA (2006) Histopathological prognostic factors in medulloblastoma: High expression of survivin is related to unfavourable outcome. Eur J Cancer 42:2996-3003
8. Sohn DM, Kim SY, Baek MJ, Lim CW, Lee MH, Cho MS, Kim TY (2006) Expression of survivin and clinical correlation in patients with breast cancer. Biomed Pharmacother 60:289-292
9. Akyürek N, Memiş L, Ekinci O, Köktürk N, Oztürk C (2006) Survivin expression in pre-invasive lesions and non-small cell lung carcinoma. Virchows Arch 449:164-170
10. Rödel F, Hoffmann J, Distel L, Herrmann M, Noisternig T, Papadopoulos T, Sauer R, Rödel C (2005) Survivin as a radioresistance factor, and prognostic and therapeutic target for radiotherapy in rectal cancer. Cancer Res 65:4881-4887
11. Yang L, Cao Z, Li F, Post DE, Van Meir EG, Zhong H, Wood WC (2004) Tumor specific gene expression using the Survivin promoter is further increased by hypoxia. Gene Ther 11:1215-1223
12. Peng XH, Karna P, Cao Z, Jiang BH, Zhou M, Yang L (2006) Cross-talk between epidermal growth factor receptor and hypoxia-inducible factor-1alpha signal pathways increases resistance to apoptosis by up-regulating survivin gene expression. J Biol Chem 281:25903-25914
13. Jiang YA, Fan LF, Jiang CQ, Zhang YY, Luo HS, Tang ZJ, Xia D, Wang M (2003) Expression and significance of PTEN, hypoxia-inducible factor-1 alpha in colorectal adenoma and adenocarcinoma. World J Gastroenterol 9:491-494
14. Matsuyama T, Nakanishi K, Hayashi T, Yoshizumi Y, Aiko S, Sugiura Y, Tanimoto T, Uenoyama M, Ozeki Y, Maehara T (2005) Expression of hypoxia-inducible factor-1alpha in esophageal squamous cell carcinoma. Cancer Sci 96:176-182
15. Vleugel MM, Greijer AE, Shvarts A, van der Groep P, van Berkel M, Aarbodem Y, van Tinteren H, Harris AL, van Diest PJ, van der Wall E (2005) Differential prognostic impact of hypoxia induced and diffuse HIF-1alpha expression in invasive breast cancer. J Clin Pathol 58:172-177
16. Zhang Q, Zhang ZF, Rao JY, Sato JD, Brown J, Messadi DV, Le AD (2004) Treatment with siRNA and antisense oligonucleotides targeted to HIF-1alpha induced apoptosis in human tongue squamous cell carcinomas. Int J Cancer 111:849-857
17. Sowter HM, Raval RR, Moore JW, Ratcliffe PJ, Harris AL (2003) Predominant role of hypoxia-inducible transcription factor (Hif)-1alpha versus Hif-2alpha in regulation of the transcriptional response to hypoxia. Cancer Res 63:6130-6134
18. Berchner-Pfannschmidt U, Petrat F, Doege K, Trinidad B, Freitag P, Metzen E, de Groot H, Fandrey J (2004) Chelation of cellular calcium modulates hypoxia-inducible gene expression through activation of hypoxia-inducible factor-1alpha. J Biol Chem 279:44976-44986
19. Itoh T, Namba T, Fukuda K, Semenza GL, Hirota K (2001) Reversible inhibition of hypoxia-inducible factor 1 activation by exposure of hypoxic cells to the volatile anesthetic halothane. FEBS Lett 509:225-229
20. Ponnelle T, Chapusot C, Martin L, Bouvier AM, Plenchette S, Faivre J, Solary E, Piard F (2005) Cellular localisation of Survivin: Impact on the prognosis in colorectal cancer. Cancer Res Clin Oncol 131:504-510
21. Tanaka K, Iwamoto S, Gon G, Nohara T, Iwamoto M, Tanigawa N (2000) Expression of survivin and its relationship to loss of apoptosis in breast carcinomas. Clin Cancer Res 6:127-134
22. Boman BM, Walters R, Fields JZ, Kovatich AJ, Zhang T, Isenberg GA, Goldstein SD, Palazzo JP (2004) Colonic crypt changes during adenoma development in familial adenomatous polyposis: Immunohistochemical evidence for expansion of the crypt base cell population. Am J Pathol 165:1489-1498
23. Tan HY, Liu J, Wu SM, Luo HS (2005) Expression of a novel apoptosis inhibitor - survivin in colorectal carcinoma. World J Gastroenterol 11:4689-4692
24. Abd El-Hameed A (2005) Survivin expression in colorectal adenocarcinoma using tissue microarray. J Egypt Natl Canc Inst 17:42-50
25. Altieri DC (2003) Validating Survivin as a cancer therapeutic target. Nat Rev Cancer 3:46-54
26. Smith SD, Wheeler MA, Plescia J, Colberg JW, Weiss RM, Altieri DC (2001) Urine detection of Survivin and diagnosis of bladder cancer. JAMA 285:324-328
27. Chang Q, Qin R, Huang T, Gao J, Feng Y (2006) Effect of antisense hypoxia-inducible factor 1alpha on progression, metastasis, and chemosensitivity of pancreatic cancer. Pancreas 32:297-305
28. Conway EM, Zwerts F, Van Eygen V, DeVriese A, Nagai N, Luo W, Collen D (2003) Survivin-dependent angiogenesis in ischemic brain. Am J Pathol 163:935-994
29. Wei H, Wang C, Chen L (2006) Proliferating cell nuclear antigen, Survivin, and CD34 expressions in pancreatic cancer and their correlation with hypoxia-inducible factor 1alpha. Pancreas 32:159-163